|
 
 |
| CORRESPONDENCE |
|
|
|
| Year : 2011 | Volume
: 29
| Issue : 1 | Page : 78-79 |
| |
First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital
IK Neonakis1, K Stylianou2, E Daphnis2, S Maraki1
1 Department of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine , University Hospital of Heraklion, 71110 Heraklion, Crete, Greece
2 Department of Nephrology, University Hospital of Heraklion, PO Box 1352, 71110 Heraklion, Crete, Greece
| Date of Submission | 07-Nov-2000 |
| Date of Acceptance | 16-Dec-2010 |
| Date of Web Publication | 7-Feb-2011 |
Correspondence Address:
I K Neonakis
Department of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine , University Hospital of Heraklion, 71110 Heraklion, Crete
Greece
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0255-0857.76535
How to cite this article:
Neonakis I K, Stylianou K, Daphnis E, Maraki S. First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital. Indian J Med Microbiol 2011;29:78-9 |
How to cite this URL:
Neonakis I K, Stylianou K, Daphnis E, Maraki S. First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital. Indian J Med Microbiol [serial online] 2011 [cited 2019 Dec 8];29:78-9. Available from: http://www.ijmm.org/text.asp?2011/29/1/78/76535 |
Dear Editor,
Currently carbapenem-resistant Klebsiella pneumoniae is one of the most problematic pathogens, as treatment has largely been limited to colistin (COL) and tigecycline (TIG). Here we present the first case of TIG-resistance in our region.
A 62-years old female with an end-stage renal disease secondary to adult dominant polycystic kidney disease (in haemodialysis for 15 years) was recurrently (12 times only in 2010) admitted due to cholangitis. Among others her prior medical history included chronic hypertension, hysterectomy (1986), recurrent pyogenic cholangitis since 2004, endoscopic sphincterotomy of Vater's ampulla and gallstones removal (2005), bilateral nephrectomy due to recurrent infections (2006) and open cholecystectomy and choledocholithotomy due to gallstones (2009). Over the last year, a variety of Gram-negative (including imipenem- and COL-resistant Acinetobacter baumannii, Pseudomonas aeruginosa and K. pneumoniae) and Gram-positive microbia (including vancomycin-resistant Enterococcus faecium) have been isolated and TIG was extensively used. K. pneumoniae was isolated from a pigtail catheter sample. Vitek-2 (bioMerieux) revealed resistance to all antimicrobials including resistance to TIG (>8 mg/L) with the exception of gentamicin (<=1 mg/L) and COL (<=0.5 mg/L). The precise MIC was further determined to be 24 mg/L with the E-test (AB Biodisk). A regiment including COL was administered and currently the patient is stable and considered for double liver and kidney transplantation.
Resistance to tigecycline has been attributed to overexpression of efflux pumps such as the AcrAB RND-type efflux pump. Until now there have only been sporadic reports on TIG-resistant K. pneumoniae isolates worldwide [1],[2],[3] . Greece has been shown to be a "hot spot" of antimicrobial resistance [4] . During 2008, in our Hospital IMP-non-susceptibility rate of K. pneumoniae reached 50% and among the IMP-resistant isolates 24% was also resistant to COL [5] . For these cases, TIG was the salvage therapy as no TIG-resistance had been previously noticed. The development of TIG-resistance is an issue of great concern and will probably lead to deaths due to untreatable infections. Appropriate policies should be urgently designed and implemented.
| ~ References | |  |
| 1. | Garrison MW, Mutters R, Dowzicky MJ. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007. Diagn Microbiol Infect Dis. 2009;65:288-99. 
[PUBMED] [FULLTEXT] |
| 2. | Elemam A, Rahimian J, Mandell W. Infection with Panresistant Klebsiella pneumoniae: A Report of 2 Cases and a Brief Review of the Literature. Clin Inf Dis 2009; 49:271-4.
|
| 3. | Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ; Hellenic Tigecycline Study Group. In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn Microbiol Infect Dis. 2010;66:187-94.
|
| 4. | Neonakis I, Gikas A, Scoulica E, Manios A, Georgiladakis A, Tselentis Y. Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: an 8-year survey in a University Hospital in Greece. Int J Antimicrob Agents 2003;22:526-531.
[PUBMED] [FULLTEXT] |
| 5. | Neonakis IK, Samonis G, H. Messaritakis H, Baritaki S, Georgiladakis A, Maraki S, Spandidos DA. Resistance status and evolution trends of Klebsiella pneumoniae isolates in a University Hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin. Chemotherapy 2010; 56:448-452.
[PUBMED] [FULLTEXT] |
| This article has been cited by | | 1 |
Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan |
|
| Yi-Tsung Lin,Fu-Der Wang,Yu-Jiun Chan,Yung-Chieh Fu,Chang-Phone Fung | | BMC Infectious Diseases. 2014; 14(1): 1 | | [Pubmed] | [DOI] | | | 2 |
Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method |
|
| Jiao Xie,Taotao Wang,Xue Wang,Xiaoliang Cheng,Haiyan Dong,Yan Wang,Xiaowei Zheng,Liang Zhou,Jianfeng Xing,Yalin Dong | | Journal of Separation Science. 2014; : n/a | | [Pubmed] | [DOI] | | | 3 |
Optimal tigecycline dosage regimen is urgently needed: results from a pharmacokinetic/pharmacodynamic analysis of tigecycline by Monte Carlo simulation |
|
| Jiao Xie,Taotao Wang,Jinyao Sun,Siying Chen,Jiangxia Cai,Weipeng Zhang,Haiyan Dong,Sasa Hu,Di Zhang,Xue Wang,Yalin Dong | | International Journal of Infectious Diseases. 2013; | | [Pubmed] | [DOI] | | | 4 |
The emergence of clinical resistance to tigecycline |
|
| Yan Sun,Yun Cai,Xu Liu,Nan Bai,Beibei Liang,Rui Wang | | International Journal of Antimicrobial Agents. 2013; 41(2): 110 | | [Pubmed] | [DOI] | | | 5 |
Zinc-dependent carbapenemases in clinical isolates of family Enterobacteriaceae |
|
| Rai, S., Manchanda, V., Singh, N.P., Kaur, I.R. | | Indian Journal of Medical Microbiology. 2011; 29(3): 275-279 | | [Pubmed] | |
|
|
|
|
|
|
|
|
